VHL-MEDIATED UBIQUITINATION OF THE KINASE MPS1 REGULATES THE MITOTIC CHECKPOINT IN CLEAR CELL RENAL CELL CARCINOMA

被引：0
|
作者：
Woodford, Mark
Backe, Sarah
Sager, Rebecca
Shapiro, Oleg
Nsouli, Imad
Wengert, Laura
Bratslavsky, Gennady
Bourboulia, Dimitra
Mollapour, Mehdi
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD01-01
引用
收藏
页码：E30 / E30
页数：1
相关论文
共 50 条
  • [41] Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma
    Zhao, Leizuo
    Wang, Zicheng
    Xu, Yingkun
    Zhang, Peizhi
    Qiu, Jiechuan
    Nie, Dengke
    Wu, Guangzhen
    Chen, Chen
    Chang, Yao
    Xia, Qinghua
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
  • [42] MPS1 kinase activity is essential for C-MAD2 production and assembly of the mitotic checkpoint complex (MCC).
    Tipton, A. R.
    Bekier, M. E., II
    Taylor, W.
    Liu, S-T.
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [43] OVEREXPRESSION OF MPS1 IN CLEAR CELL RENAL CELL CARCINOMA (CCRCC) CONFERS TUMOR SELECTIVITY ON HEAT SHOCK PROTEIN-90 (HSP90) INHIBITORS
    Abouelleil, Mourad
    Dunn, Diana
    Woodford, Mark
    Jensen, Sandra
    Chehab, Mahmoud
    Madala, Alosh
    Caza, Tiffany
    Landas, Steve
    Stetler-Stevenson, William G.
    Neckers, Len
    Bourboulia, Dimitra
    Bratslavsky, Gennady
    Mollapour, Mehdi
    JOURNAL OF UROLOGY, 2015, 193 (04): : E455 - E455
  • [44] Comprehensive genomic profiling (CGP) of VHL mutated and VHL wild type clear cell renal cell carcinoma (ccRCC)
    Bratslavsky, G.
    Grivas, P.
    Spiess, P. E.
    Decker, B.
    Danziger, N. A.
    Sokol, E.
    Ross, J. S.
    ANNALS OF ONCOLOGY, 2021, 32 : S706 - S707
  • [45] Renal Cell Carcinoma with Leiomyomatous Strome Lacks VHL Alteration: A Further Feature Differentiating It from Clear Cell Renal Cell Carcinoma
    Martignoni, G.
    Brunelli, M.
    Segala, D.
    Borze, I.
    Atanesya, L.
    Savola, S.
    Barzon, L.
    Masi, G.
    Tardanico, R.
    Eble, J. N.
    Chilosi, M.
    Bohling, T.
    Cheng, L.
    Delahunt, B.
    Gobbo, S.
    Knuutila, S.
    MODERN PATHOLOGY, 2013, 26 : 232A - 232A
  • [46] Renal Cell Carcinoma with Leiomyomatous Stroma Lacks VHL Alteration: A Further Feature Differentiating It from Clear Cell Renal Cell Carcinoma
    Martignoni, G.
    Brunelli, M.
    Segala, D.
    Borze, I.
    Atanesya, L.
    Savola, S.
    Barzon, L.
    Masi, G.
    Tardanico, R.
    Eble, J. N.
    Chilosi, M.
    Bohling, T.
    Cheng, L.
    Delahunt, B.
    Gobbo, S.
    Knuutila, S.
    LABORATORY INVESTIGATION, 2013, 93 : 232A - 232A
  • [47] Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors
    Woodford, Mark R.
    Truman, Andrew W.
    Dunn, Diana M.
    Jensen, Sandra M.
    Cotran, Richard
    Bullard, Renee
    Abouelleil, Mourad
    Beebe, Kristin
    Wolfgeher, Donald
    Wierzbicki, Sara
    Post, Dawn E.
    Caza, Tiffany
    Tsutsumi, Shinji
    Panaretou, Barry
    Kron, Stephen J.
    Trepel, Jane B.
    Landas, Steve
    Prodromou, Chrisostomos
    Shapiro, Oleg
    Stetler-Stevenson, William G.
    Bourboulia, Dimitra
    Neckers, Len
    Bratslavsky, Gennady
    Mollapour, Mehdi
    CELL REPORTS, 2016, 14 (04): : 872 - 884
  • [48] VHL-Deficient Human Kidney Organoids to Model Clear Cell Renal Cell Carcinoma
    Wang Yixuan
    Xia Yun
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [49] Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation
    Greene, Christopher J.
    Sharma, Nitika J.
    Fiorica, Peter N.
    Forrester, Emily
    Smith, Gary J.
    Gross, Kenneth W.
    Kauffman, Eric C.
    FREE RADICAL BIOLOGY AND MEDICINE, 2019, 133 : 295 - 309
  • [50] The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy
    Clark, Peter E.
    KIDNEY INTERNATIONAL, 2009, 76 (09) : 939 - 945
12345